Skip to main content

Optibrium, Molecular Networks to Share Tech Platforms

NEW YORK (GenomeWeb News) – Optibrium and Molecular Networks today said that they will share complementary technology platforms for the drug discovery market.

The collaboration will integrate Molecular Networks' 3D structure generator, Corina, into Optibrium's StarDrop, a platform for guiding compound selection and design.

According to the firms, Corina is used within StarDrop's predictive P450 metabolism models, which identify metabolic liabilities of candidate molecules against the major cytochrome P450 enzymes.

"The seamless integration of CORINA within StarDrop has enabled our P450 metabolism models to provide more reliable data in support of the drug design and optimisation process," Matthew Segall, CEO of Cambridge, UK-based Optibrium, said in a statement. "We are looking forward to providing access to more of Molecular Network's chemoinformatics tools through StarDrop to further benefit our customers."

Financial and further terms of the alliance were not disclosed.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.